Indivior PLC (INDV)
34.90
+0.30
(+0.87%)
USD |
NASDAQ |
Dec 05, 10:59
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 4.363B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 204.6% |
| Valuation | |
| PE Ratio | 34.74 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 3.734 |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -1.720 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 90.68% |
Profile
| Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA. |
| URL | http://indivior.com |
| Investor Relations URL | N/A |
| HQ State/Province | Virginia |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 19, 2026 (est.) |
| Last Earnings Release | Oct. 30, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 16, 2016 |
Ratings
Profile
| Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA. |
| URL | http://indivior.com |
| Investor Relations URL | N/A |
| HQ State/Province | Virginia |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 19, 2026 (est.) |
| Last Earnings Release | Oct. 30, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 16, 2016 |